HLB PHARMACEUTICAL CO., LTD. Logo

HLB PHARMACEUTICAL CO., LTD.

Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.

047920 | KO

Overview

Corporate Details

ISIN(s):
KR7047920004
LEI:
Country:
South Korea
Address:
경기도 남양주시 경강로 27, 남양주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pharmaceutical Co., Ltd. is a research-driven pharmaceutical company specializing in the development and manufacturing of innovative treatments. The company's core activities center on researching and developing new drugs, including peptide-based therapies and a pipeline of anti-cancer treatments, as part of its vision to become a global oncology firm. In addition to its R&D, HLB Pharmaceutical provides Contract Manufacturing Organization (CMO) services, utilizing its advanced facilities and rigorous quality management systems to produce high-quality medicines. The company also manufactures quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices, and its portfolio includes products like skeletal muscle relaxants.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.6 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.6 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.6 KB
2025-07-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 105.7 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-25 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.9 KB
2025-05-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.7 KB
2025-05-29 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-05-08 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.7 KB
2025-04-24 00:00
M&A Activity
주요사항보고서(타법인주식및출자증권양수결정)
Korean 34.7 KB
2025-04-24 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 39.9 KB

Automate Your Workflow. Get a real-time feed of all HLB PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.